Advertisement

Topics

Azeliragon: The third Alzheimer’s failure of 2018

05:25 EDT 17 Apr 2018 | Pharmaceutical Technology

After the termination of Takeda’s pioglitazone and Merck & Co.’s verubecestat, vTv Therapeutic’s azeliragon is now the third pipeline drug...
Read More...

The post Azeliragon: The third Alzheimer’s failure of 2018 appeared first on Pharmaceutical Technology.

Original Article: Azeliragon: The third Alzheimer’s failure of 2018

NEXT ARTICLE

More From BioPortfolio on "Azeliragon: The third Alzheimer’s failure of 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...